Acadia Pharmaceuticals Inc. (ACAD)

[Justfactsmam]

Seeking Alpha last night:

Acadia Pharmaceuticals (ACAD) has been on a tear lately. The stock had a strong post-election rally and has outperformed the industry over the last two months, mostly due to buyout rumors and rising expectations about Nuplazid's ramp up. The promising phase 2 data in ADP in late December helped too, though there was some confusion and some misconceptions around the actual data and what was the primary endpoint (my take on the issues is available here, only to Growth Stock Forum subscribers). The recent buyout rumors helped additionally improve investor sentiment and Acadia is now sitting near 52-week highs.

Comments 0 Add Comment